Company registration number 8015160 (England and Wales)
DR MASOOD KHAN LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
PAGES FOR FILING WITH REGISTRAR
DR MASOOD KHAN LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 5
DR MASOOD KHAN LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
1,346
14,400
Current assets
Debtors
5
4,796
23,010
Cash at bank and in hand
127,848
153,797
132,644
176,807
Creditors: amounts falling due within one year
6
(3,468)
(23,090)
Net current assets
129,176
153,717
Total assets less current liabilities
130,522
168,117
Provisions for liabilities
(337)
(3,600)
Net assets
130,185
164,517
Capital and reserves
Called up share capital
2
2
Profit and loss reserves
130,183
164,515
Total equity
130,185
164,517

For the financial year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

T he member has not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 2 February 2026 and are signed on its behalf by:
Dr M A Khan
Director
Company registration number 8015160 (England and Wales)
DR MASOOD KHAN LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
1
Accounting policies
Company information

Dr Masood Khan Limited is a private company limited by shares incorporated in England and Wales. The registered office is Xeinadin Manchester, 100 Barbirolli Square, Manchester, United Kingdom, M2 3BD.

1.1
Basis of preparation

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of freehold properties and to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Revenue comprises sales of services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

The nature, timing of satisfaction of performance obligations and significant payment terms of the company's major sources of revenue are as follows:

Revenue from contracts for the provision of professional services is recognised by reference to the stage of completion when the stage of completion, costs incurred and costs to complete can be estimated reliably. The stage of completion is calculated by comparing costs incurred, mainly in relation to contractual hourly staff rates and materials, as a proportion of total costs.

1.3
Intangible fixed assets - goodwill

Goodwill, being the amount paid in connection with the acquisition of a business in 2012, is being amortised evenly over its estimated useful life of five years.

1.4
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Computers
20% on cost
Motor vehicles
20% on reducing balance

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

DR MASOOD KHAN LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 3 -
1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price. Financial liabilities classified as payable within one year are not amortised.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised at transaction price.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

DR MASOOD KHAN LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 4 -
Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.9
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

2
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
3
3
3
Intangible fixed assets
Goodwill
£
Cost
At 1 April 2024 and 31 March 2025
20,000
Amortisation and impairment
At 1 April 2024 and 31 March 2025
20,000
Carrying amount
At 31 March 2025
-
0
At 31 March 2024
-
0
DR MASOOD KHAN LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 5 -
4
Tangible fixed assets
Plant and machinery etc
£
Cost
At 1 April 2024
46,185
Additions
709
Disposals
(40,490)
At 31 March 2025
6,404
Depreciation and impairment
At 1 April 2024
31,785
Depreciation charged in the year
495
Eliminated in respect of disposals
(27,222)
At 31 March 2025
5,058
Carrying amount
At 31 March 2025
1,346
At 31 March 2024
14,400
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
-
0
23,010
Other debtors
4,796
-
0
4,796
23,010
6
Creditors: amounts falling due within one year
2025
2024
£
£
Taxation and social security
-
0
19,191
Other creditors
3,468
3,899
3,468
23,090
2025-03-31 2024-04-01 false false false 02 February 2026 CCH Software CCH Accounts Production 2025.300 No description of principal activity Dr M A Khan Mr H A Khan Mrs A Khan Mr Z A Khan 8015160 2024-04-01 2025-03-31 8015160 2025-03-31 8015160 2024-03-31 8015160 core:OtherPropertyPlantEquipment 2025-03-31 8015160 core:OtherPropertyPlantEquipment 2024-03-31 8015160 core:CurrentFinancialInstruments core:WithinOneYear 2025-03-31 8015160 core:CurrentFinancialInstruments core:WithinOneYear 2024-03-31 8015160 core:WithinOneYear 2025-03-31 8015160 core:WithinOneYear 2024-03-31 8015160 core:CurrentFinancialInstruments 2025-03-31 8015160 core:CurrentFinancialInstruments 2024-03-31 8015160 core:ShareCapital 2025-03-31 8015160 core:ShareCapital 2024-03-31 8015160 core:RetainedEarningsAccumulatedLosses 2025-03-31 8015160 core:RetainedEarningsAccumulatedLosses 2024-03-31 8015160 bus:Director1 2024-04-01 2025-03-31 8015160 core:Goodwill 2024-04-01 2025-03-31 8015160 core:ComputerEquipment 2024-04-01 2025-03-31 8015160 core:MotorVehicles 2024-04-01 2025-03-31 8015160 2023-04-01 2024-03-31 8015160 core:NetGoodwill 2024-03-31 8015160 core:NetGoodwill 2025-03-31 8015160 core:NetGoodwill 2024-03-31 8015160 core:OtherPropertyPlantEquipment 2024-03-31 8015160 core:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 8015160 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 8015160 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 8015160 bus:FRS102 2024-04-01 2025-03-31 8015160 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 8015160 bus:Director2 2024-04-01 2025-03-31 8015160 bus:Director3 2024-04-01 2025-03-31 8015160 bus:Director4 2024-04-01 2025-03-31 8015160 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP